A detailed history of Raymond James Financial Inc transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 10,550 shares of HCAT stock, worth $23,948. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,550
Previous 90,432 88.33%
Holding current value
$23,948
Previous $340,000 91.18%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$2.7 - $4.09 $215,681 - $326,717
-79,882 Reduced 88.33%
10,550 $30,000
Q2 2025

Aug 14, 2025

SELL
$3.58 - $4.52 $429,596 - $542,395
-119,999 Reduced 57.03%
90,432 $340,000
Q1 2025

May 13, 2025

SELL
$3.97 - $7.42 $312,383 - $583,850
-78,686 Reduced 27.22%
210,431 $953,000
Q4 2024

Feb 06, 2025

BUY
$6.9 - $9.02 $1.99 Million - $2.61 Million
289,117 New
289,117 $2.04 Million

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $124M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Raymond James Financial Inc Portfolio

Follow Raymond James Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Inc with notifications on news.